NCT07759869: A Study to Evaluate the Long-term Safety of HS-10380 in Patients With Schizophrenia
- State
- Not started
- Phase
- Phase 3
- People
- 500 planned
- Started
- 9 Sep 2026
- Primary completion
- 31 Jul 2028
- Arms
- HS-10380 (1.5-6mg)
- Results
- None posted
- 12 Aug 2026: Trial registered